Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Overall Study	STARTED	Trimethoprim-Sulfamethoxazole	302
Overall Study	STARTED	Placebo	305
Overall Study	Completed Outcome Renal Scan	Trimethoprim-Sulfamethoxazole	227
Overall Study	Completed Outcome Renal Scan	Placebo	235
Overall Study	Completed Assessments for New Scarring	Trimethoprim-Sulfamethoxazole	220
Overall Study	Completed Assessments for New Scarring	Placebo	227
Overall Study	Outcome Stool Assessed	Trimethoprim-Sulfamethoxazole	203
Overall Study	Outcome Stool Assessed	Placebo	210
Overall Study	Recurrent UTI With E. Coli	Trimethoprim-Sulfamethoxazole	30
Overall Study	Recurrent UTI With E. Coli	Placebo	57
Overall Study	Recurrent UTI With TMP-SMZ Panel	Trimethoprim-Sulfamethoxazole	38
Overall Study	Recurrent UTI With TMP-SMZ Panel	Placebo	69
Overall Study	COMPLETED	Trimethoprim-Sulfamethoxazole	261
Overall Study	COMPLETED	Placebo	259
Overall Study	NOT COMPLETED	Trimethoprim-Sulfamethoxazole	41
Overall Study	NOT COMPLETED	Placebo	46

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00405704/flow